Navigating the Canadian copyright scene presents a unique challenge. Legally speaking , dimethyltryptamine (copyright) remains strictly prohibited across the country . There are no licensed sources obtainable for acquisition . However, surprisingly, the legal status of psilocybin, and the increasing acceptance of copyright therapy , have triggered